Lipopolysaccharide-activated microglia lower P-glycoprotein function in brain microvascular endothelial cells

Junichi Matsumoto1, Shinya Dohgu, Fuyuko Takata

  • 1Department of Pharmaceutical Care and Health Sciences, Faculty of Pharmaceutical Sciences, Fukuoka University, Fukuoka, Japan.

Neuroscience Letters
|July 18, 2012
PubMed

Insights

Activated microglia impair blood-brain barrier (BBB) P-glycoprotein (P-gp) function via NADPH oxidase, increasing substance accumulation in brain endothelial cells. This dysfunction occurs without altering P-gp expression levels.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Cell Biology

Background:

  • P-glycoprotein (P-gp) is a key efflux transporter at the blood-brain barrier (BBB), regulating compound traffic.
  • Microglial activation and BBB disruption often occur concurrently under pathological conditions.
  • Previous research indicates lipopolysaccharide (LPS)-activated microglia increase endothelial cell permeability via NADPH oxidase.

Purpose of the Study:

  • To investigate the link between LPS-activated microglia and P-glycoprotein (P-gp) dysfunction at the BBB.
  • To examine the effect of LPS on P-gp function in a rat brain endothelial cell (RBEC)/microglia coculture system.

Main Methods:

  • Utilized a coculture system of RBECs and rat microglia.
  • Applied LPS to the abluminal side of RBEC monolayers and cocultures.
  • Assessed cellular accumulation of the P-gp substrate rhodamine 123.
  • Investigated the role of NADPH oxidase using its inhibitor, diphenyleneiodoniumchloride.

Main Results:

  • LPS treatment in RBEC/microglia cocultures significantly increased rhodamine 123 accumulation in RBECs.
  • This increased accumulation was effectively blocked by diphenyleneiodoniumchloride, indicating NADPH oxidase involvement.
  • LPS did not alter P-gp expression levels in either RBEC monolayers or cocultures.

Conclusions:

  • Activated microglia induce P-glycoprotein (P-gp) dysfunction at the blood-brain barrier (BBB).
  • This dysfunction is mediated through an NADPH oxidase-dependent pathway.
  • P-gp expression remains unaffected, suggesting a functional impairment rather than a change in transporter quantity.

Related Concept Videos